Posted in | News

Accel Energy Group Announces Major Launch Into Road Construction Projects in China

Jul 21 2005

Related Stories

Accel Energy Group announced today a major launch into road construction projects in China with its new product SAB. SAB is a binder ingredient that is used in asphalt. The product is derived from oil shale, and makes roads more durable so they last longer.

China is planning an extensive highway system that will link all provinces and major economic centers. The estimated annual budget expenditures for China's road construction are projected to be 10.8 billion dollars with annual increases of about 2-4 billion dollars.

Anthony Chirico, CEO of Accel Energy Group, stated, "This is an exciting time for AGYG. Our company has been cultivating relationships in China since 1985, and we are positioned to expand this market after years of general building and road construction. AGYG owns the SAB patent pending and currently has plans in place to manufacture the product in China."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit
Reducing Embodied Carbon Through Design

Reducing Embodied Carbon Through Design

With an increase in the pressure to decarbonize the built environment and build more carbon-neutral buildings, the reduction of embodied carbon has become of great importance.

Calcium Carbonate Concrete: Building on Recycling

Calcium Carbonate Concrete: Building on Recycling

AZoBuild talks to Professors Noguchi and Maruyama about their research and development of Calcium Carbonate Concrete (CCC), a new material that has the potential to cause a sustainable revolution in the construction industry.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback